The Antiobesity Effects of Centrally Administered Neuromedin U and Neuromedin S Are Mediated Predominantly by the Neuromedin U Receptor 2 (NMUR2)
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Neuromedin U (NMU) and neuromedin S (NMS) are structurally related neuropeptides that have been reported to modulate energy homeostasis. Pharmacological data have shown that NMU and NMS inhibit food intake when administered centrally and that NMU increases energy expenditure. Additionally, NMU-deficient mice develop obesity, whereas transgenic mice overexpressing NMU are lean and hypophagic. Two high-affinity NMU/NMS receptors, NMUR1 and NMUR2, have been identified. NMUR1 is predominantly expressed in the periphery, whereas NMUR2 is predominantly expressed in the brain, suggesting that the effects of centrally administered NMU and NMS are mediated by NMUR2. To evaluate the role of NMUR2 in the regulation of energy homeostasis, we characterized NMUR2-deficient (Nmur2−/−) mice. Nmur2−/− mice exhibited a modest resistance to diet-induced obesity that was at least in part due to reduced food intake. Acute central administration of NMU and NMS reduced food intake in wild-type but not in Nmur2−/− mice. The effects on activity and core temperature induced by centrally administered NMU were also absent in Nmur2−/− mice. Moreover, chronic central administration of NMU and NMS evoked significant reductions in body weight and sustained reductions in food intake in mice. In contrast, Nmur2−/− mice were largely resistant to these effects. Collectively, these data demonstrate that the anorectic and weight-reducing actions of centrally administered NMU and NMS are mediated predominantly by NMUR2, suggesting that NMUR2-selective agonists may be useful for the treatment of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of neuromedin S and its possible role in the mammalian circadian oscillator system
Mori, K., Miyazato, M., Ida, T., Murakami, N., Serino, R., Ueta, Y., Kojima, M., & Kangawa, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600526 · Cited by 183
Ballesta, J., Carlei, F., Bishop, A. E., Steel, J. H., Gibson, S. J., Fahey, M., Hennessey, R., Domin, J., Bloom, S. R., & Polak, J. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90037-1 · Cited by 121
Austin, C., Lo, G., Nandha, K. A., Meleagros, L., & Bloom, S. R. (1995) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0140157 · Cited by 79
Augood, S. J., Keast, J. R., & Emson, P. C. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90063-8 · Cited by 63
Cited by
Lin, H. V., Frassetto, A., Kowalik Jr, E. J., Nawrocki, A. R., Lu, M. M., Kosinski, J. R., Hubert, J. A., Szeto, D., Yao, X., Forrest, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035240 · Cited by 1,378
Self-citationGenetics and epigenetics of eating disorders
Bulik, C., Yilmaz, Z., & HArdaway, A. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s55776 · Cited by 278
A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States
Chiu, C. N., Rihel, J., Lee, D. A., Singh, C., Mosser, E. A., Chen, S., Sapin, V., Pham, U., Engle, J., Niles, B. J., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.007 · Cited by 101
“Intriguingly, nmur2 knock-out mice were reported to not exhibit locomotor activity phenotypes, although behavior was only monitored for short time intervals during the day (Peier et al., 2009; Zeng et al., 2006).”
BackgroundResultInfluentialNovak, C. M. (2009) · Endocrinology · doi:10.1210/en.2009-0448 · Cited by 12
Metadata
- Authors
- Peier, A., Kosinski, J., Cox-York, K., Qian, Y., Desai, K., Feng, Y., Trivedi, P., Hastings, N., & Marsh, D. J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-03-26
- Volume
- 150
- Issue
- 7
- Pages
- 3101-3109
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2075522667
- Cited by
- 74
- References
- 4
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Antiobesity Effects of Centrally Administered Neuromedin U and Neuromedin S Are Mediated Predominantly by the Neuromedin U Receptor 2 (NMUR2). https://app.cochat.ai/papers/10.1210/en.2008-1772
- The paper
- Peier, A., Kosinski, J., Cox-York, K., Qian, Y., Desai, K., Feng, Y., Trivedi, P., Hastings, N., & Marsh, D. J. (2009). The Antiobesity Effects of Centrally Administered Neuromedin U and Neuromedin S Are Mediated Predominantly by the Neuromedin U Receptor 2 (NMUR2). Endocrinology. https://doi.org/10.1210/en.2008-1772
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.